<DOC>
	<DOCNO>NCT02791958</DOCNO>
	<brief_summary>This study compare pharmacodynamics Fixed Dose Combination Pill AAR ( acetylsalicylic acid 100 mg , atorvastatin 40 mg ramipril 10 mg ) respective reference product , atorvastatin ( Lipitor® ) 40 mg ramipril ( Altace® ) 10 mg .</brief_summary>
	<brief_title>Pharmacodynamic Equivalence Ramipril 10 mg Atorvastatin 40 mg Administered Cardiovascular ( CV ) Polypill Acetylsalicylic Acid-Atorvastatin-Ramipril ( AAR ) Compared Monotherapy</brief_title>
	<detailed_description />
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Ramipril</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Male female patient age ≥18 &lt; 75 year . Patients Stage 1 ( SBP/DBP : 140159/9099 mmHg ) Stage 2 ( SBP/DBP : ≥160/≥100 mmHg ) hypertension , either untreated wash period . Patients LDL cholesterol level ≥100 mg/dL , either untreated wash period . Patients untreated BP lower / lipid lower medication Patients treat BP lower / lipid lower medication include medication safely withdraw per physician 's judgment . Provide write informed consent . Patients BMI &gt; 35 SBP &lt; 140 mmHg DBP &lt; 90 mmHg Severe hypertension define SBP &gt; 180 mmHg Diastolic Blood Pressure ( DBP ) &gt; 110 mmHg LDL cholesterol level &lt; 100 mg/dL , either untreated wash period . Serum triglyceride concentration ≥400 mg/dL , either untreated wash period . Patients medical condition require chronic pharmacological treatment list : Cytochrome P450 3A4 ( CYP3A4 ) inhibitor ( eg itraconazole , ketoconazole , erythromycin , clarithromycin , telithromycin , HIV protease inhibitor , nefazodone ) . Nonsteroidal antiinflammatory drug ( NSAIDs ) . Ksparing diuretic . Lithium . Amiodarone verapamil . Oral anticoagulant ( eg , warfarin ) . Steroids . Digoxin . Gemfibrozil . Niacin . Potassium supplement . Cyclosporine . Danazol . Rifampicin . Evidence know clinically significant chronic disease Patients renal impairment Creatinine Clearance ( CrCl ) &lt; 40 mL/ min/ 1.73 m2 Creatine phosphokinase ( CPK ) ≥5 x upper limit normal ( ULN ) . Alanine aminotransferase ( ALT ) aspartate aminotransferase ( AST ) ≥ 3 x ULN . Total bilirubin ≥1.5 x ULN Medical history evidence drug alcohol abuse . Medical history gastrointestinal bleeding gastroduodenal ulcer . Presence secondary dyslipidemia . For patient antihypertensive and/ cholesterol lower medication impossibility withdraw safely per physician 's judgment Previous coronary artery bypass graft ( CABG ) . Previous percutaneous transluminal coronary angioplasty ( PTCA ) drugeluting stent . Presence severe congestive heart failure ( New York Heart Classification ( NYHC ) III IV ) . Prior history stroke , Transient Ischemic Attack ( TIA ) , Myocardial Infarction ( MI ) , cardiomyopathy systolic dysfunction ( prior document Left Ventricular Ejection Fraction ( LVEF ) &lt; 40 % ) Aspirin induce asthma Previous intolerance and/or hypersensitivity ACE inhibitor , statin and/or salicylate . Presence unstable angina . Lab value specify central laboratory normal range consider clinically significant . Patients partner use effective contraception method ( i.e . intra uterine device ( IUD ) condom diaphragm spermicide condom ) study least one month thereafter , oral contraceptive allow . Pregnant , lactating , breastfeeding , intend become pregnant course study ( female ) . All woman must negative urine pregnancy test Screening Visit , surgically sterile ( bilateral tubal ligation , bilateral oophorectomy , hysterectomy ) postmenopausal status ( menses ) least one year . Presence mental illness limit capacity selfcare . Presence major systemic illness : renal disease , liver disease , neurological psychiatric disease . Participation , 30 day precede enrolment study , clinical study investigational market drug employ . Any medical condition investigator opinion may interfere study procedure and/or evaluation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>